scispace - formally typeset
K

Kei Tobiume

Researcher at Tokyo Medical and Dental University

Publications -  11
Citations -  5915

Kei Tobiume is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: ASK1 & MAP kinase kinase kinase. The author has an hindex of 8, co-authored 9 publications receiving 5654 citations. Previous affiliations of Kei Tobiume include Japanese Foundation for Cancer Research.

Papers
More filters
Journal ArticleDOI

Chemical inhibition of LSD1 leads to epithelial to mesenchymal transition in vitro of an oral squamous cell carcinoma OM-1 cell line via release from LSD1-dependent suppression of ZEB1.

TL;DR: In this paper , an adverse effect against cancer therapeutics, which was EMT induction in vitro by the chemical LSD1 inhibitor, was reported, and an additional EMT-TF Snail-dependent partial EMT phenotype in OM-1 progressed to complete EMT in conjunction with LSD 1 inhibitor-dependent ZEB1 induction.